Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03164616
Brief Title: Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). (POSEIDON)

First Submitted : May 22, 2017
First Submitted that Met QC Criteria : May 22, 2017
First Posted : May 23, 2017

Results First Submitted : March 11, 2022
Results First Submitted that Met QC Criteria : March 11, 2022
Results First Posted : April 7, 2022

Last Update Submitted that Met QC Criteria : June 6, 2022
Last Update Posted : June 7, 2022